Selected research
Market Structure
Global Glyburide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Glyburide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Glyburide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glyburide include Sunlight Pharmaceutical, Double Whale Pharmaceutical, Shapuaisi Pharma, Novartis, Jisheng Medicine, CR Sanjiu, Bohai Pharmaceutical, Sanofi Aventis and Physicians Total Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glyburide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glyburide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glyburide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glyburide market size, projected growth trends, production technologies, key applications, and end-use industries.
Glyburide Segment by Company
Sunlight Pharmaceutical
Double Whale Pharmaceutical
Shapuaisi Pharma
Novartis
Jisheng Medicine
CR Sanjiu
Bohai Pharmaceutical
Sanofi Aventis
Physicians Total Care
Hoechst Canada
Hikma Pharmaceuticals
Dominion Pharmacal
Cadila Pharmaceuticals
Avanstra
Apotex Corporation
Amneal Pharmaceuticals
Glyburide Segment by Type
1.25mg
2.5mg
5mg
Glyburide Segment by Application
Pediatric Use
Geriatric Use
Others
Glyburide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glyburide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glyburide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glyburide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glyburide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glyburide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glyburide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Glyburide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 1.25mg
- 2.5mg
- 5mg
Applications
- Pediatric Use
- Geriatric Use
- Others
Companies covered
- Sunlight Pharmaceutical
- Double Whale Pharmaceutical
- Shapuaisi Pharma
- Novartis
- Jisheng Medicine
- CR Sanjiu
- Bohai Pharmaceutical
- Sanofi Aventis
- Physicians Total Care
- Hoechst Canada
- Hikma Pharmaceuticals
- Dominion Pharmacal
- Cadila Pharmaceuticals
- Avanstra
- Apotex Corporation
- Amneal Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Glyburide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Glyburide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Glyburide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Glyburide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Glyburide Market Dynamics
- 2.1 Glyburide Industry Trends
- 2.2 Glyburide Industry Drivers
- 2.3 Glyburide Industry Opportunities and Challenges
- 2.4 Glyburide Industry Restraints
3 Glyburide Market by Manufacturers
- 3.1 Global Glyburide Revenue by Manufacturers (2021-2026)
- 3.2 Global Glyburide Sales by Manufacturers (2021-2026)
- 3.3 Global Glyburide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Glyburide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glyburide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glyburide Manufacturers, Product Type & Application
- 3.7 Global Glyburide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glyburide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glyburide Players Market Share by Revenue in 2025
- 3.8.3 2025 Glyburide Tier 1, Tier 2, and Tier 3
4 Glyburide Market by Type
- 4.1 Glyburide Type Introduction
- 4.1.1 1.25mg
- 4.1.2 2.5mg
- 4.1.3 5mg
- 4.2 Global Glyburide Sales by Type
- 4.2.1 Global Glyburide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glyburide Sales by Type (2021-2032)
- 4.2.3 Global Glyburide Sales Market Share by Type (2021-2032)
- 4.3 Global Glyburide Revenue by Type
- 4.3.1 Global Glyburide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glyburide Revenue by Type (2021-2032)
- 4.3.3 Global Glyburide Revenue Market Share by Type (2021-2032)
5 Glyburide Market by Application
- 5.1 Glyburide Application Introduction
- 5.1.1 Pediatric Use
- 5.1.2 Geriatric Use
- 5.1.3 Others
- 5.2 Global Glyburide Sales by Application
- 5.2.1 Global Glyburide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glyburide Sales by Application (2021-2032)
- 5.2.3 Global Glyburide Sales Market Share by Application (2021-2032)
- 5.3 Global Glyburide Revenue by Application
- 5.3.1 Global Glyburide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glyburide Revenue by Application (2021-2032)
- 5.3.3 Global Glyburide Revenue Market Share by Application (2021-2032)
6 Global Glyburide Sales by Region
- 6.1 Global Glyburide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glyburide Sales by Region (2021-2032)
- 6.2.1 Global Glyburide Sales by Region (2021-2026)
- 6.2.2 Global Glyburide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Glyburide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Glyburide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Glyburide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Glyburide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Glyburide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Glyburide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Glyburide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Glyburide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Glyburide Revenue by Region
- 7.1 Global Glyburide Revenue by Region
- 7.1.1 Global Glyburide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Glyburide Revenue by Region (2021-2026)
- 7.1.3 Global Glyburide Revenue by Region (2027-2032)
- 7.1.4 Global Glyburide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Glyburide Revenue (2021-2032)
- 7.2.2 North America Glyburide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Glyburide Revenue (2021-2032)
- 7.3.2 Europe Glyburide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Glyburide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Glyburide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Glyburide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Glyburide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sunlight Pharmaceutical
- 8.1.1 Sunlight Pharmaceutical Company Information
- 8.1.2 Sunlight Pharmaceutical Business Overview
- 8.1.3 Sunlight Pharmaceutical Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sunlight Pharmaceutical Glyburide Product Portfolio
- 8.1.5 Sunlight Pharmaceutical Recent Developments
- 8.2 Double Whale Pharmaceutical
- 8.2.1 Double Whale Pharmaceutical Company Information
- 8.2.2 Double Whale Pharmaceutical Business Overview
- 8.2.3 Double Whale Pharmaceutical Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Double Whale Pharmaceutical Glyburide Product Portfolio
- 8.2.5 Double Whale Pharmaceutical Recent Developments
- 8.3 Shapuaisi Pharma
- 8.3.1 Shapuaisi Pharma Company Information
- 8.3.2 Shapuaisi Pharma Business Overview
- 8.3.3 Shapuaisi Pharma Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shapuaisi Pharma Glyburide Product Portfolio
- 8.3.5 Shapuaisi Pharma Recent Developments
- 8.4 Novartis
- 8.4.1 Novartis Company Information
- 8.4.2 Novartis Business Overview
- 8.4.3 Novartis Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Novartis Glyburide Product Portfolio
- 8.4.5 Novartis Recent Developments
- 8.5 Jisheng Medicine
- 8.5.1 Jisheng Medicine Company Information
- 8.5.2 Jisheng Medicine Business Overview
- 8.5.3 Jisheng Medicine Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jisheng Medicine Glyburide Product Portfolio
- 8.5.5 Jisheng Medicine Recent Developments
- 8.6 CR Sanjiu
- 8.6.1 CR Sanjiu Company Information
- 8.6.2 CR Sanjiu Business Overview
- 8.6.3 CR Sanjiu Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CR Sanjiu Glyburide Product Portfolio
- 8.6.5 CR Sanjiu Recent Developments
- 8.7 Bohai Pharmaceutical
- 8.7.1 Bohai Pharmaceutical Company Information
- 8.7.2 Bohai Pharmaceutical Business Overview
- 8.7.3 Bohai Pharmaceutical Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bohai Pharmaceutical Glyburide Product Portfolio
- 8.7.5 Bohai Pharmaceutical Recent Developments
- 8.8 Sanofi Aventis
- 8.8.1 Sanofi Aventis Company Information
- 8.8.2 Sanofi Aventis Business Overview
- 8.8.3 Sanofi Aventis Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sanofi Aventis Glyburide Product Portfolio
- 8.8.5 Sanofi Aventis Recent Developments
- 8.9 Physicians Total Care
- 8.9.1 Physicians Total Care Company Information
- 8.9.2 Physicians Total Care Business Overview
- 8.9.3 Physicians Total Care Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Physicians Total Care Glyburide Product Portfolio
- 8.9.5 Physicians Total Care Recent Developments
- 8.10 Hoechst Canada
- 8.10.1 Hoechst Canada Company Information
- 8.10.2 Hoechst Canada Business Overview
- 8.10.3 Hoechst Canada Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hoechst Canada Glyburide Product Portfolio
- 8.10.5 Hoechst Canada Recent Developments
- 8.11 Hikma Pharmaceuticals
- 8.11.1 Hikma Pharmaceuticals Company Information
- 8.11.2 Hikma Pharmaceuticals Business Overview
- 8.11.3 Hikma Pharmaceuticals Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hikma Pharmaceuticals Glyburide Product Portfolio
- 8.11.5 Hikma Pharmaceuticals Recent Developments
- 8.12 Dominion Pharmacal
- 8.12.1 Dominion Pharmacal Company Information
- 8.12.2 Dominion Pharmacal Business Overview
- 8.12.3 Dominion Pharmacal Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Dominion Pharmacal Glyburide Product Portfolio
- 8.12.5 Dominion Pharmacal Recent Developments
- 8.13 Cadila Pharmaceuticals
- 8.13.1 Cadila Pharmaceuticals Company Information
- 8.13.2 Cadila Pharmaceuticals Business Overview
- 8.13.3 Cadila Pharmaceuticals Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Cadila Pharmaceuticals Glyburide Product Portfolio
- 8.13.5 Cadila Pharmaceuticals Recent Developments
- 8.14 Avanstra
- 8.14.1 Avanstra Company Information
- 8.14.2 Avanstra Business Overview
- 8.14.3 Avanstra Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Avanstra Glyburide Product Portfolio
- 8.14.5 Avanstra Recent Developments
- 8.15 Apotex Corporation
- 8.15.1 Apotex Corporation Company Information
- 8.15.2 Apotex Corporation Business Overview
- 8.15.3 Apotex Corporation Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Apotex Corporation Glyburide Product Portfolio
- 8.15.5 Apotex Corporation Recent Developments
- 8.16 Amneal Pharmaceuticals
- 8.16.1 Amneal Pharmaceuticals Company Information
- 8.16.2 Amneal Pharmaceuticals Business Overview
- 8.16.3 Amneal Pharmaceuticals Glyburide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Amneal Pharmaceuticals Glyburide Product Portfolio
- 8.16.5 Amneal Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glyburide Value Chain Analysis
- 9.1.1 Glyburide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glyburide Production Mode & Process
- 9.2 Glyburide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glyburide Distributors
- 9.2.3 Glyburide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst